Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00225745 · ClinicalTrials.gov registry record

Ghrelin Levels in Pancreatic Cancer Patients

A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
72
Enrollment target

NCT00225745 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00225745 has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
72 participants
Enrollment target

Study Summary

The primary outcome measure for this study is plasma ghrelin level.

Interventions

  • PROCEDURE Blood draw

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2004-04
Est. Completion 2015-09

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT00225745

The ClinicalTrials.gov registry entry for NCT00225745 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.

NCT00225745 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00225745 about?

NCT00225745 is a clinical study titled "Ghrelin Levels in Pancreatic Cancer Patients". The primary outcome measure for this study is plasma ghrelin level.

What is the current status of trial NCT00225745?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2004-04. Estimated completion is 2015-09.

What interventions are being tested in trial NCT00225745?

The interventions under investigation include: Blood draw (PROCEDURE).

Who is sponsoring clinical trial NCT00225745?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.